日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Helminth exposure and immune response to the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen

蠕虫暴露与两剂异源Ad26.ZEBOV、MVA-BN-Filo埃博拉疫苗方案的免疫反应

Barry, Houreratou; Lhomme, Edouard; Surénaud, Mathieu; Nouctara, Moumini; Robinson, Cynthia; Bockstal, Viki; Valea, Innocent; Somda, Serge; Tinto, Halidou; Meda, Nicolas; Greenwood, Brian; Thiébaut, Rodolphe; Lacabaratz, Christine

Safety and Immunogenicity of an Accelerated Ebola Vaccination Schedule in People with and without Human Immunodeficiency Virus: A Randomized Clinical Trial

加速埃博拉疫苗接种方案在感染和未感染人类免疫缺陷病毒人群中的安全性和免疫原性:一项随机临床试验

Ake, Julie A; Paolino, Kristopher; Hutter, Jack N; Cicatelli, Susan Biggs; Eller, Leigh Anne; Eller, Michael A; Costanzo, Margaret C; Paquin-Proulx, Dominic; Robb, Merlin L; Tran, Chi L; Anova, Lalaine; Jagodzinski, Linda L; Ward, Lucy A; Kilgore, Nicole; Rusnak, Janice; Bounds, Callie; Badorrek, Christopher S; Hooper, Jay W; Kwilas, Steven A; Ilsbroux, Ine; Anumendem, Dickson Nkafu; Gaddah, Auguste; Shukarev, Georgi; Bockstal, Viki; Luhn, Kerstin; Douoguih, Macaya; Robinson, Cynthia

Prediction of long-term humoral response induced by the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola

预测两剂异源Ad26.ZEBOV、MVA-BN-Filo疫苗诱导的埃博拉病毒长期体液免疫反应

Alexandre, Marie; Prague, Mélanie; McLean, Chelsea; Bockstal, Viki; Douoguih, Macaya; Thiébaut, Rodolphe

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

在塞拉利昂儿童中,两剂异源Ad26.ZEBOV和MVA-BN-Filo埃博拉疫苗方案的安全性和免疫原性:一项随机、双盲、对照试验

Afolabi, Muhammed O; Ishola, David; Manno, Daniela; Keshinro, Babajide; Bockstal, Viki; Rogers, Baimba; Owusu-Kyei, Kwabena; Serry-Bangura, Alimamy; Swaray, Ibrahim; Lowe, Brett; Kowuor, Dickens; Baiden, Frank; Mooney, Thomas; Smout, Elizabeth; Köhn, Brian; Otieno, Godfrey T; Jusu, Morrison; Foster, Julie; Samai, Mohamed; Deen, Gibrilla Fadlu; Larson, Heidi; Lees, Shelley; Goldstein, Neil; Gallagher, Katherine E; Gaddah, Auguste; Heerwegh, Dirk; Callendret, Benoit; Luhn, Kerstin; Robinson, Cynthia; Greenwood, Brian; Leyssen, Maarten; Douoguih, Macaya; Leigh, Bailah; Watson-Jones, Deborah

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

在塞拉利昂成人中,两剂异源Ad26.ZEBOV和MVA-BN-Filo埃博拉疫苗方案的安全性和长期免疫原性:一项开放标签、非随机I期试验和一项随机、双盲、对照II期试验的联合研究

Ishola, David; Manno, Daniela; Afolabi, Muhammed O; Keshinro, Babajide; Bockstal, Viki; Rogers, Baimba; Owusu-Kyei, Kwabena; Serry-Bangura, Alimamy; Swaray, Ibrahim; Lowe, Brett; Kowuor, Dickens; Baiden, Frank; Mooney, Thomas; Smout, Elizabeth; Köhn, Brian; Otieno, Godfrey T; Jusu, Morrison; Foster, Julie; Samai, Mohamed; Deen, Gibrilla Fadlu; Larson, Heidi; Lees, Shelley; Goldstein, Neil; Gallagher, Katherine E; Gaddah, Auguste; Heerwegh, Dirk; Callendret, Benoit; Luhn, Kerstin; Robinson, Cynthia; Leyssen, Maarten; Greenwood, Brian; Douoguih, Macaya; Leigh, Bailah; Watson-Jones, Deborah

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial

在非洲儿童和青少年中,接种两剂异源Ad26.ZEBOV、MVA-BN-Filo埃博拉疫苗的安全性和免疫原性:一项随机、安慰剂对照、多中心II期临床试验

Anywaine, Zacchaeus; Barry, Houreratou; Anzala, Omu; Mutua, Gaudensia; Sirima, Sodiomon B; Eholie, Serge; Kibuuka, Hannah; Bétard, Christine; Richert, Laura; Lacabaratz, Christine; McElrath, M Juliana; De Rosa, Stephen C; Cohen, Kristen W; Shukarev, Georgi; Katwere, Michael; Robinson, Cynthia; Gaddah, Auguste; Heerwegh, Dirk; Bockstal, Viki; Luhn, Kerstin; Leyssen, Maarten; Thiébaut, Rodolphe; Douoguih, Macaya

Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola

非人灵长类动物到人类的免疫桥接实验表明,Ad26.ZEBOV、MVA-BN-Filo疫苗对埃博拉病毒具有保护作用。

Bockstal, Viki; Leyssen, Maarten; Heerwegh, Dirk; Spiessens, Bart; Robinson, Cynthia; Stoop, Jeroen N; Roozendaal, Ramon; Van Effelterre, Thierry; Gaddah, Auguste; Van Roey, Griet A; Solforosi, Laura; Zahn, Roland; Callendret, Benoit; Hendriks, Jenny; Luhn, Kerstin; Douoguih, Macaya; Schuitemaker, Hanneke; Van Hoof, Johan

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa

在非洲开展的一项随机、安慰剂对照的II期临床试验中,对健康成人和HIV感染成人接种两剂异源Ad26.ZEBOV、MVA-BN-Filo埃博拉疫苗的安全性和免疫原性进行了评估。

Barry, Houreratou; Mutua, Gaudensia; Kibuuka, Hannah; Anywaine, Zacchaeus; Sirima, Sodiomon B; Meda, Nicolas; Anzala, Omu; Eholie, Serge; Bétard, Christine; Richert, Laura; Lacabaratz, Christine; McElrath, M Juliana; De Rosa, Stephen; Cohen, Kristen W; Shukarev, Georgi; Robinson, Cynthia; Gaddah, Auguste; Heerwegh, Dirk; Bockstal, Viki; Luhn, Kerstin; Leyssen, Maarten; Douoguih, Macaya; Thiébaut, Rodolphe

Assessments of different batches and dose levels of a two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen

对两剂Ad26.ZEBOV和MVA-BN-Filo疫苗方案的不同批次和剂量水平进行评估

Bockstal, Viki; Gaddah, Auguste; Goldstein, Neil; Shukarev, Georgi; Bart, Stephan; Luhn, Kerstin; Robinson, Cynthia; Anumendem, Dickson; Leyssen, Maarten; Douoguih, Macaya

Durable natural killer cell responses after heterologous two-dose Ebola vaccination.

异源两剂埃博拉疫苗接种后产生持久的自然杀伤细胞反应

Wagstaffe Helen R, Susannini Giada, Thiébaut Rodolphe, Richert Laura, Lévy Yves, Bockstal Viki, Stoop Jeroen N, Luhn Kerstin, Douoguih Macaya, Riley Eleanor M, Lacabaratz Christine, Goodier Martin R